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Abstract
Background: Thyrotoxicosis after total thyroidectomy is mostly iatrogenic. Rarely, a hyperfunctional thyroid remnant
or ectopic tissue may be the cause. There are few cases of Graves’ disease arising from thyroid tissue located
in the mediastinum and none in which Graves’ disease was diagnosed only after surgery. We report the case of a patient
with Graves’s disease in a mediastinal thyroid mass presenting 7 years after total thyroidectomy for nontoxic goiter.
Case presentation: A 67-year-old Caucasian woman presented with palpitations, fatigue and weight loss. She had
a history of total thyroidectomy for nontoxic multinodular goiter at the age of 60 without any signs of malignancy on
microscopic examination. She had been medicated with levothyroxine 100 μg/day since the surgery without
follow-up. She was tachycardic, had no cervical mass or eye involvement. Her thyroid-stimulating hormone
levels were suppressed (0.000 μU/mL) and her free thyroxine (3.22 ng/dL) and free triiodothyronine (8.46 pg/mL) levels
increased. Neither mediastinal enlargement nor trachea deviation was found on chest roentgenogram. Levothyroxine
treatment was stopped but our patient showed no improvement on free thyroxine or free triiodothyronine 10 days
later. Thyroglobulin was increased to 294 mg/mL. A cervical ultrasound scan revealed no thyroid remnant. Her
anti-thyroid-stimulating hormone receptor antibodies were high (19.7 U/L). Corporal scintigraphy demonstrated
increased intrathoracic radioiodine uptake. A computed tomography scan confirmed a 60 × 40 mm mediastinal mass.
Methimazole 10 mg/day was started. Three months later, her thyroid function was normal and she underwent surgical
resection. Microscopic examination showed thyroid tissue with no signs of malignancy.
Conclusions: Although thyrotoxicosis after total thyroidectomy is mostly due to excessive supplementation, true
hyperthyroidism may rarely be the cause, which should be kept in mind. The presence of thyroid tissue after total
thyroidectomy in our patient may correspond to a remnant or ectopic thyroid tissue that became hyperfunctional in
the presence of anti- thyroid-stimulating hormone receptor antibodies.
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Background
Graves’ disease is the most common cause of hyperthy-
roidism [1]. Thyrotoxicosis after total thyroidectomy is
mainly due to supratherapeutic doses of levothyroxine;
other possible, although more rare etiologies are a hyper-
functional thyroid remnant or ectopic thyroid tissue [2].
The presence of a thyroid remnant after total thyroid-
ectomy is not infrequent. When total thyroidectomy is
performed for benign pathology, the estimated recur-
rence rate is 0–0.3 % [3, 4]. This possibly represents an
underestimation since only symptomatic recurrence
was detected. If ultrasonography is performed to detect
the presence of a thyroid remnant, the recurrence rate
can reach 33 % [5]. Recurrence is mostly due to the
presence of an embryologic thyroid remnant along the
pyramidal or thyrothymic tract that can be missed
during surgery [4].
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The existence of ectopic thyroid tissue is a rare dis-
order that results from an abnormal migration of the
thyroid gland during embryological development. It is
not a frequently encountered entity in everyday clinical
practice – prevalence of 1:100,000 to 1:300,000 – but in
autopsy studies its prevalence is higher – from 7–10 %
[6, 7]. It appears that the existence of ectopic thyroid
tissue is relatively common, but most of the time asymp-
tomatic and thus undetected. The ectopic thyroid tissue
can be affected by the same diseases that involve the
thyroid gland [6, 7]. An intrathoracic location of thyroid
tissue is uncommon and it usually coexists with a nor-
mally functioning thyroid gland. An intrathoracic ectopic
thyroid may be asymptomatic or present with compressive
symptoms [6].
We present the case of a 67-year-old woman previously
submitted to total thyroidectomy for a multinodular
nontoxic goiter who presented with hyperthyroidism.
Case presentation
A 67-year-old Caucasian woman was admitted to the
emergency department with palpitations, and dizziness
in the past 2 days. She complained of fatigue after minor
effort, weight loss (11 kg in 3 years) without anorexia,
and hand tremor. She had no complaints of dyspnea,
orthopnea or chest pain. She had no heat intolerance
nor increased frequency of bowel movements.
Our patient had a history of breast cancer diagnosed
at the age of 37 and treated with right radical mastec-
tomy and adjuvant chemotherapy. She underwent total
thyroidectomy for nontoxic multinodular goiter [thy-
roid-stimulating hormone (TSH) 3.77 of μU/mL and free
thyroxine (T4) of 1.53 ng/dL] with a dominant colloid
nodule of 30 mm at the age of 60; the histological analysis
confirmed multinodular adenomatous goiter weighing
66 g with no signs of malignancy. She was medicated
with levothyroxine 100 μg/day since the surgery and
had no follow-up. She smoked 20 cigarettes a day for
the last 50 years.
At physical examination, our patient was conscious and
oriented. Her temperature was 36.7 °C, she had a body
mass index of 19.7 kg/m2, blood pressure of 122/76 mmHg,
a heart rate of 130 bpm, and fine tremor at rest. She had
no eye involvement. A cervical examination showed no
palpable masses or adenomegaly. Pemberton’s sign was
negative. The pulmonary sounds were normal and she had
no cardiac murmur. She had no peripheral edema.
At admission, our patient had a hemoglobin level of
11.5 g/L (12–16); a normal white blood cell and platelet
count; a normal liver panel; an albumin level of 32.6 g/dL
(38–51); normal renal function and ionogram; corrected
total calcium level of 9.6 mg/dL (8.1–10.4); B-type natri-
uretic peptide level of 442.2 pg/mL (<100); and a troponin
I level <0.010 ng/mL. She had suppressed levels of TSH
(0.000 μU/mL) and increased levels of free T4 3.22
ng/dL (0.70–1.48) and free triiodothyronine (T3) 8.46
pg/mL (1.71–3.71). In the electrocardiogram, she had
sinus tachycardia of 117 bpm and incomplete right
bundle branch block and left anterior fascicle block.
Her chest roentgenogram showed normal cardiothor-
acic index, no pulmonary congestion, no mediastinal
enlargement nor tracheal deviation.
She was admitted to the endocrinology department with
a diagnosis of iatrogenic thyrotoxicosis. She was started
on bisoprolol 5 mg and levothyroxine was stopped. Her
heart rate remained under 100 bpm and her blood pres-
sure was always normal. Her extremities’ rest tremor per-
sisted. She showed no improvement on her free T4 and
free T3 levels 10 days after levothyroxine treatment with-
drawal (Table 1). Her thyroglobulin levels were increased
to 294 mg/mL (0–55). A cervical ultrasound scan revealed
no thyroid remnant in the gland bed. Test results for anti-
TSH receptor antibodies (TRAb) were positive – 19.7 U/L
(<1.8) – and for anti-thyroperoxidase antibodies were
negative – 0.6 U/mL (<5.61). Corporal scintigraphy with
I-131 with single-photon emission computed tomography
(SPECT) revealed an intrathoracic mass (60 × 40 mm)
with increased radioiodine uptake and no increased up-
take in the thyroid bed (Fig. 1). A computed tomography
(CT) scan of her neck and thorax confirmed a heteroge-
neous mass with 67 × 46 × 52 mm in the anterior medias-
tinum superiorly (Figs. 2 and 3).
The final diagnosis was Graves’ disease in mediastinal
thyroid tissue. She was discharged with bisoprolol 5 mg/
day and methimazole 10 mg/day.
Three months later, after achieving euthyroidism, she
underwent surgical resection of the mass through a hori-
zontal cervical incision. The thyroid tissue found in the su-
perior mediastinum had cervical vascularization. There was
no complication in the postoperative period. The histology
showed hyperfunctional tissue with thyroid follicles of vari-
able shape and form with papillary hyperplasia and some
adenomatous areas; no signs of malignancy were found.
Our patient remained asymptomatic and with normal
thyroid function under levothyroxine 88 μg/day (1.6 μg/kg)
5 months after surgery.
Table 1 Evolution of thyroid function
D1 D10 D13 3 monthsa 8 monthsb
Free T3 (1.71–3.71 pg/mL) 8.46 7.19 9.31 3.02
Free T4 (0.70–1.48 ng/dL) 3.22 3.19 3.11 1.38 1.42
TSH (0.35–4.94 μU/mL) 0.000 0.002 1.26
D1 at admission, D10 10 days after admission, D13 13 days after admission
(at discharge), T3 triiodothyronine, T4 thyroxine, TSH thyroid-stimulating hormone
a3 months after discharge and under methimazole 10 mg/day treatment
b8 months after discharge and 5 months after surgery and supplemented with
levothyroxine 88 μg/day
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Discussion
We present the case of a patient with Graves’s disease in
mediastinal thyroid tissue years after total thyroidectomy
for a nontoxic multinodular goiter. There are few case
reports of Graves’ disease arising from non-normally lo-
cated thyroid tissue [8–13] and even fewer from thyroid
tissue located in the mediastinum [2, 14–18]. In all
cases, either Graves’ disease was diagnosed prior to the
surgery and then detected in the mediastinum [14, 18];
or the ectopic tissue was first noted during the evaluation
of hyperthyroidism [15, 16]. In one case, the ectopic tissue
was removed due to compressive symptoms and recurred
9 years later when Graves’ disease developed [17]. To the
best of our knowledge, there are no reports of mediastinal
thyroid tissue first presenting as hyperthyroidism without
previous known history of such condition, neither in truly
ectopic tissue nor in a surgical thyroid remnant. The ab-
sence of reports of hyperthyroidism in surgical remnants
may represent a publication bias: physicians tend to not
report eventual surgical failures. Nonetheless, a complete
lack of published cases argues for the rarity of this case
presentation.
Although the great majority of cases of thyrotoxicosis
after total thyroidectomy are caused by excessive levothyr-
oxine therapy, true cases of hyperthyroidism must not be
forgotten. Ectopic thyroid tissue or a thyroid remnant may
become hyperfunctional, as any thyroid gland. An import-
ant clue is the failure of the thyroid hormone levels to
normalize after reduction or even withdrawal of levothyr-
oxine as was the case in our patient. Another sign may be
Fig. 1 Corporal scintigraphy with I-131 with single-photon emission computed tomography showing an intrathoracic mass (60 × 40 mm)
with increased radioiodine uptake
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an elevated thyroglobulin level. Thyroglobulin is useful to
detect residual thyroid tissue after total thyroidectomy
and has an important place in the follow-up of patients
with differentiated thyroid cancers [19]. Nonetheless, it
can be helpful in distinguishing between truly endogenous
thyroid production and an exogenous source [1]. Thyro-
globulin levels were increased in our patient pointing
toward the presence of functional thyroid tissue. Scintig-
raphy is a very useful method to detect any functional
thyroid tissue and its location. In the presented case,
whole body scintigraphy revealed a mediastinal mass with
increased radioiodine uptake.
The presence of thyroid tissue after total thyroidec-
tomy may correspond to a remnant, ectopic thyroid or
metastatic tissue [2]. The presence of a remnant is the
most usual cause of residual thyroid tissue [4, 5, 18, 20].
The reported recurrence rate of benign multinodular
goiter after total thyroidectomy ranges between as low
as 0.33 %, when recurrence is defined by the need of a
second surgery [4], to as much as 33 % when based on
ultrasonographic examination [5]. A remnant was de-
tected in as many as 93.1 % of patients with differenti-
ated thyroid carcinoma after total thyroidectomy when
scintigraphy was performed [20]. A “forgotten goiter” is
a portion of the thyroid gland located in the mediasti-
num missed in the previous total thryroidectomy [2, 18].
This term refers to thyroid tissue that is neither visibly
connected to the cervical gland nor truly ectopic tissue.
The blood supply of this tissue is usually derived from
cervical blood vessels, which makes it an important sign
in the differential diagnosis [2, 18]. A remnant of non-
toxic multinodular goiter is not clinically relevant most
of the time since they are usually small sized [5]. Never-
theless, a remnant may assume clinical significance in
the presence of stimulating anti-TSH receptor immuno-
globulins and consequent hyperfunction [10].
The presence of ectopic thyroid tissue is rare [6, 21]. In
normal embryological development, the thyroid is formed
from an endodermal diverticulum in the pharyngeal gut at
the 24th day of gestation. It then migrates downward
along the midline from the foramen cecum until it reaches
its final pretracheal position. Ectopic thyroid tissue results
from an abnormal migration along this path [6, 22]. The
most common location is the base of the tongue but it
may be found as far as the mediastinum or even the
abdominal cavity [6]. The mediastinum is a rare location
for ectopic thyroid tissue and, when present, it normally
coexists with an orthotopic gland and patients are euthyr-
oid [6]. Ectopic thyroid tissue may develop benign or
Fig. 3 Neck and thorax computed tomography scan – coronal (left) and sagittal sections (right)
Fig. 2 Neck and thorax computed tomography scan showing the
heterogeneous 67 × 46 × 52 mm mass in the anterior mediastinum
– axial section
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malign pathology usually found in the “normal” thyroid
gland [6, 7]. The differentiation between thyroid remnant
and ectopic thyroid tissue is not always easy after total
thyroidectomy [2].
A thyroid cancer metastasis should always be kept in
mind when thyroid tissue is identified in a non-normal
location [6].
In the particular case of our patient, it is possible that
the non-normally located thyroid tissue may have gone
unnoticed while still functioning normally. The diagnosis of
hyperfunction associated with the development of Graves’
disease was further delayed because our patient was on
levothyroxine supplementation. Malignant cells were not
found on histological examination, excluding the hypothesis
of neoplasia. Whether the mediastinal thyroid tissue found
in our patient corresponds to truly ectopic tissue with no
attachment to the orthotopic thyroid gland, or represents
thyroid tissue not removed in the previous surgery that
increased in size under stimulation of the anti-TSH
receptors antibodies with the onset of the autoimmune
disease remains unknown, but the presence of cervical
vascularization argues in favor of the latter [6]. The decision
between surgical or radioiodine treatment was made in
accordance with our patient’s personal preferences.
Conclusions
Although thyrotoxicosis after total thyroidectomy is mostly
due to excessive supplementation, physicians should keep
in mind the possibility of true hyperthyroidism. The pres-
ence of thyroid tissue after total thyroidectomy in our
patient may correspond to a remnant or, less likely, ectopic
thyroid tissue that became hyperfunctional in the presence
of TRAbs.
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